Novo Nordisk
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.About NVO
Novo Nordisk A/S is a global healthcare company, which engages in the the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Biopharm segments.
NVO Key Statistics
NVO News
Novo Nordisk A/S NVO successfully defended two pivotal patent claims linked to the main ingredient in its popular weight-loss and diabetes drugs, Wegovy and Oze...
COPENHAGEN, Oct 3 (Reuters) - The CEO of Novo Holdings, the controlling shareholder in drugmaker Novo Nordisk (NOVOb.CO), said on Tuesday he sees the window for...
Semaglutides—weight loss and diabetes injectables like Wegovy, Ozempic, and Rybelsus—significantly improved blood sugar control and weight in adults with type 2...
Analyst ratings
61%
of 28 ratingsNVO Earnings
More NVO News
Novo Nordisk (NVO) closed the most recent trading day at $91.80, moving +0.95% from the previous trading session. This move outpaced the S&P 500's daily gain of...
FILE PHOTO: Flags with the Novo Nordisk logo flutter outside their Danish company's offices in Copenhagen By Blake Brittain WASHINGTON (Reuters) - A U.S. Pate...
U.S. President Joe Biden delivers remarks on Social Security and Medicare at the University of Tampa in Tampa, Florida, U.S. February 9, 2023. REUTERS/Jonathan...
Oct 2 (Reuters) - Novo Nordisk said on Monday the U.S. Food and Drug Administration (FDA) had approved its therapy to treat a rare genetic condition that affect...
PLAINSBORO, N.J., Oct. 2, 2023 /PRNewswire/ -- Novo Nordisk announced today that the U.S. Food and Drug Administration (FDA) has approved RivflozaTM (nedosiran)...
Novo Nordisk A/S Bagsværd, Denmark, 02 October 2023 – On 10 August 2023, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Re...
Shares of Structure Therapeutics rose more than 30% on Friday after the biotech startup's experimental obesity pill succeeded in a small early-stage trial. The...